Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Metabolic States of the Body: The Postabsorptive State

Metabolic States of the Body: The Postabsorptive State

The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...

Metabolic States of the Body: Fasting and Starvation

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...

Metabolic States of the Body: The Absorptive State

Metabolic States of the Body: The Absorptive State

During the absorptive state, which lasts approximately four hours after a meal, the body absorbs nutrients from the gastrointestinal tract. The carbohydrates, proteins, and lipids we consume are broken down into monosaccharides, amino acids, and free fatty acids for absorption. While carbohydrates and proteins are absorbed as-is, lipids are absorbed in their broken-down forms and then re-esterified into triglycerides within enterocytes before being packaged into chylomicrons. These absorbed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Postmarket Surveillance of Mesh Performance After Inguinal Hernia Repair.

JAMA surgery·2025

Same author

Stress and corticotropin releasing factor (CRF) promote necrotizing enterocolitis in a formula-fed neonatal rat model.

PloS one·2021

Same author

Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.

The international journal of neuropsychopharmacology·2015

Same author

Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects.

Journal of clinical pharmacology·2014

Same author

Pure transvaginal ventral hernia repair in humans.

Surgical innovation·2013

Same author

Transvaginal cholecystectomy: effect on quality of life and female sexual function.

JAMA surgery·2013

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Roux-en-Y Gastric Bypass Operation in Rats

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

Metabolic and nutritional changes after bariatric surgery.

Bernard S Salameh¹, Bernard Salemeh, Maya T Khoukaz

¹Resident in General Surgery, Yale University School of Medicine, New Haven, CT 06510, USA.

Expert Review of Gastroenterology & Hepatology

|March 31, 2010

Summary

Bariatric surgery offers durable weight loss for severe obesity, improving obesity-related conditions. Patients require lifelong vitamin supplementation and monitoring for nutrient deficiencies after these procedures.

More Related Videos

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Related Experiment Videos

Last Updated: Jun 14, 2026

Roux-en-Y Gastric Bypass Operation in Rats

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Area of Science:

Metabolic and Bariatric Surgery
Obesity Medicine
Surgical Gastroenterology

Background:

Severe obesity is a complex condition requiring durable interventions.
Bariatric surgery is indicated for individuals with a body mass index (BMI) ≥ 40 kg/m² or BMI ≥ 35 kg/m² with weight-related comorbidities.
Surgical procedures aim to limit food intake (restrictive), decrease nutrient absorption (malabsorptive), or combine both approaches.

Purpose of the Study:

To review the types of bariatric surgery and their outcomes.
To highlight the benefits of bariatric surgery in resolving obesity-related comorbidities.
To emphasize the importance of lifelong nutritional monitoring post-surgery.

Main Methods:

Classification of bariatric procedures into restrictive, malabsorptive, and combined categories.
Discussion of the Roux-en-Y gastric bypass as a current gold standard.
Review of potential postoperative metabolic and micronutrient deficiencies.

Main Results:

Malabsorptive procedures may yield greater weight loss but are associated with more metabolic issues.
The Roux-en-Y gastric bypass offers significant weight loss with fewer complications but necessitates lifelong vitamin supplementation.
Bariatric surgery effectively improves or resolves numerous obesity-related comorbidities, including diabetes, hypertension, and sleep apnea.

Conclusions:

Bariatric surgery is the most effective long-term treatment for severe obesity.
Careful patient selection and lifelong adherence to nutritional guidelines are crucial for successful outcomes.
The resolution of comorbidities like type 2 diabetes can be attributed to weight loss and potential alterations in the enteroinsular axis.